| Literature DB >> 33941447 |
Lu Yan1, Alejandra Rodríguez-delaRosa1, Olivier Pourquié2.
Abstract
Human pluripotent stem cells (PSCs), which have the capacity to self-renew and differentiate into multiple cell types, offer tremendous therapeutic potential and invaluable flexibility as research tools. Recently, remarkable progress has been made in directing myogenic differentiation of human PSCs. The differentiation strategies, which were inspired by our knowledge of myogenesis in vivo, have provided an important platform for the study of human muscle development and modeling of muscular diseases, as well as a promising source of cells for cell therapy to treat muscular dystrophies. In this review, we summarize the current state of skeletal muscle generation from human PSCs, including transgene-based and transgene-free differentiation protocols, and 3D muscle tissue production through bioengineering approaches. We also highlight their basic and clinical applications, which facilitate the study of human muscle biology and deliver new hope for muscular disease treatment.Entities:
Keywords: Human pluripotent stem cells (PSCs); Muscular dystrophy; Myogenesis; Satellite cells; Skeletal muscle; Tissue engineering
Mesh:
Year: 2021 PMID: 33941447 PMCID: PMC8530835 DOI: 10.1016/j.semcdb.2021.04.017
Source DB: PubMed Journal: Semin Cell Dev Biol ISSN: 1084-9521 Impact factor: 7.727